Overview ( as on 11/02/26 )

NAV
₹110.07
Last change
₹1.08 +0.01%
Fund Size (AUM)
7875.40 Cr
Performance
16.55% (5Y)

Fund Details

logo
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl
as of 11/02/26
AUM

7875.40 Cr

Expense Ratio

1.82 %

Benchmark

BSE Healthcare TR INR

ISIN

INF204K01943

Fund Manager

Sailesh Raj Bhan

Exit Load

1.0% if redeemed within 0-1 months

0% if redeemed after 1 months

Fund Performance 1Y 3Y 5Y
Nippon India Pharma Fund Reinvestment Inc Dist cum Cap Wdrl 2.19% 21.22% 16.55%
BSE Healthcare TR INR -1.09% 22.5% 14.92%

Top 10 Holdings

Sun Pharmaceuticals Industries Ltd
12.67%

Lupin Ltd
7.88%

Divi's Laboratories Ltd
6.54%

Dr Reddy's Laboratories Ltd
6.06%

Cipla Ltd
5.88%

Apollo Hospitals Enterprise Ltd
5.73%

Medplus Health Services Ltd
3.68%

Vijaya Diagnostic Centre Ltd
3.51%

Ajanta Pharma Ltd
3.39%

GlaxoSmithKline Pharmaceuticals Ltd
2.78%

Sector Allocation

Healthcare
100.0%

Asset Allocation

  • 99%

    Equity

  • 1%

    Others

  • 0%

    Debt

Risk and Return Category

Risk v/s Category

  • Low
  • Below Average
  • Average
  • Above Average
  • High

Return v/s Category

  • Low
  • Below Average
  • Average
  • Above Average
  • High

Related Funds

Investment Performance

If you invested in this fund:
₹
In the past (time duration):
Calculate
Total value today:
Returns:
₹ 0
+0%
If you invested in this fund:
₹
In the past (time duration):
Calculate
Total value today:
Returns:
₹ 0
+0%
Minimum SIP
100.0
Minimum Lumpsum
5000.0
Start Investing

Mutual funds by category

Expert Thoughts

...
General

Tools To Use On Fisdom for Personal Finance

...
Investment

SIPs and The Butterfly Effect

...
Personal Finance

The Optimistic Route: Mutual Funds